4.9
폐부종은 폐의 간질과 폐포 공간에 체액이 축적되어 가스 교환과 산소 공급을 방해하는 현상입니다. 심인성 또는 비심인성 모두 산소 공급과 폐 순응도를 감소시킵니다.
심인성 부종은 주로 심근경색, 심부전, 또는 판막 질환으로 인한 좌심실 기능 장애로 인해 폐 모…
심인성 폐부종은 일반적으로 심부전에서 볼 수 있는 좌심실 기능 장애에서 시작됩니다.
이로 인해 폐 모세혈관의 정수압이 상승하여 모세혈관에서 간질로 순액이 이동하고 폐포가 침수하게 됩니다.
반면, 비심원성 부종에서는 주요 기전이 모세혈관 투과성 증가이며, 이는 급성 호흡곤란 증후군이나 독성 흡입의 발생에 의해 유발됩니다.
단백질이 풍부한 액체가 폐포로 새어 들어가면서 추가적인 수분을 삼투압적으로 끌어들입니다.
두 경우 모두 폐포액이 계면활성제를 방해하고 표면장력을 증가시키며 폐의 순응을 감소시켜 호흡을 더 어렵게 만듭니다. 가스 교환은 확산 거리 증가와 환기-관류 불일치로 인해 감소합니다.
치료하지 않으면 폐부종이 심한 호흡곤란 또는 호흡 곤란으로 진행될 수 있습니다; 저산소증, 즉 혈중 산소 부족; 그리고 고탄산수증, 즉 이산화탄소 수치 상승.
View the full transcript and gain access to JoVE Core videos
Q1: What causes cardiogenic pulmonary edema?
Cardiogenic pulmonary edema results from left ventricular dysfunction, commonly seen in heart failure, myocardial infarction, or valvular disease. This dysfunction raises hydrostatic pressure in pulmonary capillaries, disrupting the balance between hydrostatic and oncotic forces. Fluid moves from capillaries into interstitial and alveolar spaces, impairing gas exchange and causing hypoxemia and dyspnea.
Q2: How does noncardiogenic pulmonary edema develop differently from cardiogenic edema?
Noncardiogenic edema occurs with normal hydrostatic pressure but increased capillary permeability due to injury or inflammation of the alveolar-capillary membrane. Conditions like acute respiratory distress syndrome or toxic inhalation damage endothelial barriers, allowing protein-rich fluid to leak into alveoli. This high-protein fluid draws in additional water osmotically, worsening edema without cardiac dysfunction.
Q3: How does pulmonary edema affect lung compliance and breathing?
Fluid accumulation in alveoli disrupts surfactant, increases surface tension, and reduces lung compliance, making alveolar expansion difficult. Increased diffusion distance and ventilation-perfusion mismatch further impair gas exchange. These changes force the respiratory muscles to work harder, increasing breathing effort and contributing to dyspnea and reduced oxygenation.
Q4: What are the severe complications of untreated pulmonary edema?
Untreated pulmonary edema can progress to acute respiratory failure, characterized by severe dyspnea, hypoxemia (low blood oxygen), and hypercapnia (elevated carbon dioxide). Fluid-filled alveoli cannot participate in gas exchange, leading to refractory hypoxemia. Prompt identification of the underlying cause is critical, as cardiogenic and noncardiogenic edema require distinct treatment strategies to restore adequate gas exchange.
Q5: Why does protein-rich fluid worsen noncardiogenic pulmonary edema?
In noncardiogenic edema, damaged alveolar-capillary membranes allow protein-rich fluid to leak into alveoli. The high protein concentration creates an osmotic gradient that draws additional water into the alveolar space, amplifying fluid accumulation. This mechanism differs from cardiogenic edema, where hydrostatic pressure drives fluid movement without significant protein leakage.
Q6: How does pulmonary edema impair gas exchange?
Fluid-filled alveoli cannot participate in gas exchange, increasing the diffusion distance between blood and air. Ventilation-perfusion mismatch occurs when fluid blocks ventilation to perfused areas. Together, these changes reduce oxygen uptake and carbon dioxide elimination, causing hypoxemia and hypercapnia that characterize respiratory failure if severe.
Q7: Why is distinguishing between cardiogenic and noncardiogenic edema important for treatment?
Cardiogenic and noncardiogenic pulmonary edema require distinct treatment strategies because they result from different pathophysiologic mechanisms. Cardiogenic edema stems from left ventricular dysfunction and elevated hydrostatic pressure, while noncardiogenic edema involves increased capillary permeability. Patients with respiratory complications may also benefit from understanding chronic obstructive pulmonary disease clinical manifestations to recognize overlapping symptoms.